4.6 Article

Natural anti-inflammatory compounds for the management and adjuvant therapy of inflammatory bowel disease and its drug delivery system

Journal

ARCHIVES OF PHARMACAL RESEARCH
Volume 32, Issue 7, Pages 997-1004

Publisher

PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-009-1704-1

Keywords

Mastic oil; Inflammatory Bowel Disease (IBD); Crohn Disease (CD); Drug Delivery System (DDS); Colon targeting; pH dependent polymer

Funding

  1. Jeil Pharmaceutical Co. Ltd.

Ask authors/readers for more resources

This project aims to investigate the anti-inflammatory properties of mastic [(Pistacia lentiscus var. Chia (Anacardiaceae)] extracted from the Chios mastic plant to help reduce intestinal inflammation in inflammatory bowel disease patients. Mastic and mastic resin were obtained from the Chios Mastiha Growers Association (www.mastihashop.com). The resin was ground into a fine powder using a pestle and mortar and formulated in factorial design manner. Evaluation of the efficacy of specific anti-inflammatory/antioxidant compounds in mitigating the clinical colitis parameters in a mouse model of colitis were performed with mastic itself and combination of tocopherol compounds. Colonic drug delivery system was developed consisting of two compartment model and its release profile was also investigated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available